title: Dexmethylphenidate for attention deficit hyperactivity disorder.
abstract: BACKGROUND
  Dexmethylphenidate is a single-isomer stimulant medication approved for the treatment of attention deficit hyperactivity disorder (ADHD). Single-isomer drugs have the potential for decreased undesired effects and improved therapeutic efficacy. Stimulant medications have been the mainstay treatments for ADHD for fifty years, and ability to reduce their adverse effects would be useful in promoting patient compliance with treatment.
  
  
  OBJECTIVE
  To review the literature on the safety and efficacy of dexmethylphenidate.
  
  
  METHODS
  MedLine, PubMed search of dexmethylphenidate research.
  
  
  CONCLUSIONS
  Dexmethylphenidate is a safe and effective treatment for ADHD. Its overall safety and tolerability profile is similar to other members of the psychostimulant class.
authors.affiliation: The Ohio State University College of Medicine, Department of Pediatrics, 1581 Dodd Drive, Columbus, Ohio 43210, USA. Daniel.Coury@NationwideChildrens.org
authors.forename: Daniel
authors.initials: D
authors.lastname: Coury
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D064699:Dexmethylphenidate Hydrochloride; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*
chemical_list: D000697:Central Nervous System Stimulants; D064699:Dexmethylphenidate Hydrochloride; D008774:Methylphenidate